Global Implantable Infusion Pumps Market Size, Trends, and Growth Opportunity, By Product Type (Piston Type Infusion Pumps, Elastomeric Pump, Insulin Pump, Syringe Pump, Creeping Type Infusion Pumps, Enteral Pump), Application (Cancer Treatment, Gastroenterology, Hematology, Pediatrics, Spasticity, Analgesia, Diabetes Mellitus, Others), End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others) By Region and forecast till 2030.
Global Implantable Infusion Pumps Market
Global Implantable Infusion Pumps Market was valued at USD 18.29 billion in 2022 and is slated to reach USD 27.63 billion by 2030 at a CAGR of 5.29% from 2023-2030.
The body of the patient is infused with fluids and nutrients utilizing implantable infusion pump systems, accessories, and software at clinics, hospitals, ambulatory centers, and at home. These are frequently used in hematology, gastrointestinal, pediatrics/neonatology, gastroenterology, pain management, diabetes, general infusion, and pain control.
Market Drivers
Several businesses are concentrating more on releasing smart infusion pumps. Health monitoring gadgets are increasingly using wireless technology, which improves usability, connectivity, and data analysis. With the inclusion of wireless technology, data can be transferred from the device to a smartphone or other wireless device via Bluetooth or another cellular connection for data processing. This processing can then be utilized for research and to assess the person's health. This promotes market expansion. As the older population grows and societal norms change, chronic illnesses, and disorders are spreading around the world. Implantable infusion pumps provide lower drug dosages and typically more effective pain management for conditions like chronic arachnoiditis. The World Health Organisation predicts that by 2020, the incidence of chronic diseases will increase by 57%. Consequently, there is an increase in demand for implantable infusion pumps.
Market Restraints
A significant barrier to the market's expansion is the safety issue around implanted infusion pumps. For patients with implantable infusion pumps, the MRI environment is extremely dangerous. The U.S. Food and drug administration (U.S. FDA) has received evidence of serious adverse effects, including patient damage and death, related to implantable infusion pumps used in the field of magnetic resonance imaging (MR).
Covid-19 Impact
The epidemic has also disrupted the supply chain, resulting in a lack of the raw ingredients and parts required to make implantable infusion pumps. Delays in production and delivery as a result have reduced the number of patients who can access these devices. Additionally, the pandemic has led to a decline in elective procedures, which may have lowered the need for implantable infusion pumps for infusion in some areas.
Recent Development
In August 2022, the US FDA approved the new Novum IQ Syringe Infusion Pump (SYR) with Dose IQ Safety Software, which is made by Baxter International (US).
The creator of infusion sets, Capillary Biomedical (US), was bought by Tandem Diabetes Care (US) in July 2022. Tandem Diabetes Care's product line has now been widened to include infusion pumps.
In March 2022, the US FDA granted Fresenius Kabi (Germany) approval for the wireless Agilia Connect Infusion System, which includes the Agilia Volumetric Pump and the Agilia Syringe Pump with Vigilant Software Suite-Vigilant Master Med technology.
Market Segmentation
Global Implantable Infusion Pumps Market is segmented into By Product Type, Application, and End-User. Product Types such as Piston Type Infusion Pumps, Elastomeric Pumps, Insulin Pumps, Syringe pumps, Creeping Type Infusion Pumps, and Enteral Pumps. By Applications such as Cancer Treatment, Gastroenterology, Hematology, Pediatrics, Spasticity, Analgesia, Diabetes Mellitus, and Others. By End-User such as Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others.
Regional Analysis
Global Implantable Infusion Pumps Market is segmented into five regions Americas, Europe, Asia-Pacific, and the Middle East & Africa. The market for implantable infusion pumps is anticipated to expand in Asia-Pacific during the projected period as a result of the region's increased prevalence of chronic diseases like cancer, diabetes, and cardiovascular diseases. Additionally, declining treatment costs are opening doors for the infusion business and fueling market expansion. Because of the expanding use of specialized infusion pumps for the treatment of chronic illnesses and the rising prevalence of these illnesses, North America will continue to have a dominant position in the market throughout the projection period. Additionally, the region's huge number of hospitals and expanding geriatric population both contribute to the market's growth rate.
Key Players
This report includes a list of numerous Key Players, BD (U.S.), Hoffmann-La Roche Ltd (Switzerland), B.Braun Melsungen AG (Germany), Novo Nordisk A/S (Denmark), Medtronic (Ireland), Teleflex Incorporated (U.S.), Pfizer Inc.(U.S.), Baxter (U.S.), AngioDynamics (U.S.), Smith + Nephew (U.S.), Johnson and Johnson Services, Inc. (U.S.).
Market Taxonomy
By Product Type
• Piston Type Infusion Pumps
• Creeping Type Infusion Pumps
• Enteral Pump
• Elastomeric Pump
• Insulin Pump
• Syringe Pump
By Application
• Cancer Treatment
• Cancer pain
• Noncancerous pain
• Mixed sarcoma
• Skin cancers
• Gastric cancer
• Spasticity
• Analgesia
• Diabetes Mellitus
• Gastroenterology
• Hematology
• Pediatrics
• Others
By End User
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Europe
o Germany
o France
o UK
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest Middle East & Africa
Global Implantable Infusion Pumps Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Implantable Infusion Pumps Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing Economic Downturn
4.2.6 Post Covid-19 World Supply and Demand Conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Implantable Infusion Pumps Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Implantable Infusion Pumps Market Share Analysis, By Product Type
5.3 Global Implantable Infusion Pumps Market Size and Forecast, By Product Type
5.3.1 Piston Type Infusion Pumps
5.3.2 Creeping Type Infusion Pumps
5.3.3 Enteral Pump
5.3.4 Elastomeric Pump
5.3.5 Insulin Pump
5.3.6 Syringe Pump
6 Global Implantable Infusion Pumps Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Implantable Infusion Pumps Market Share Analysis, By Application
6.3 Global Implantable Infusion Pumps Market Size and Forecast, By Application
6.3.1 Cancer Treatment
6.3.2 Cancer pain
6.3.3 Noncancerous pain
6.3.4 Mixed sarcoma
6.3.5 Skin cancers
6.3.6 Gastric cancer
6.3.7 Spasticity
6.3.8 Analgesia
6.3.9 Diabetes Mellitus
6.3.10 Gastroenterology
6.3.11 Hematology
6.3.12 Pediatrics
6.3.13 Others
7 Global Implantable Infusion Pumps Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Implantable Infusion Pumps Market Share Analysis, By End User
7.3 Global Implantable Infusion Pumps Market Size and Forecast, By End User
7.3.1 Hospitals
7.3.2 Ambulatory Surgical Centers
7.3.3 Specialty Clinics
7.3.4 Others
8 Global Implantable Infusion Pumps Market, By Region
8.1 Global Implantable Infusion Pumps Market Share Analysis, By Region
8.2 Global Implantable Infusion Pumps Market Share Analysis, By Region
8.3 Global Implantable Infusion Pumps Market Size and Forecast, By Region
9 North America Implantable Infusion Pumps Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Implantable Infusion Pumps Market Share Analysis, By Product Type
9.3 North America Implantable Infusion Pumps Market Size and Forecast, By Application
9.4 North America Implantable Infusion Pumps Market Size and Forecast, By End User
9.5 North America Implantable Infusion Pumps Market Size and Forecast, By Country
9.5.1 U.S.
9.5.1.1 Market Size and Forecast, By Product Type
9.5.1.2 Market Size and Forecast, By Application
9.5.1.3 Market Size and Forecast, By End User
9.5.2 Canada
9.5.2.1 Market Size and Forecast, By Product Type
9.5.2.2 Market Size and Forecast, By Application
9.5.2.3 Market Size and Forecast, By End User
9.5.3 Mexico
9.5.3.1 Market Size and Forecast, By Product Type
9.5.3.2 Market Size and Forecast, By Application
9.5.3.3 Market Size and Forecast, By End User
10 Europe Implantable Infusion Pumps Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Implantable Infusion Pumps Market Share Analysis, By Product Type
10.3 Europe Implantable Infusion Pumps Market Size and Forecast, By Application
10.4 Europe Implantable Infusion Pumps Market Size and Forecast, By End User
10.5 Europe Implantable Infusion Pumps Market Size and Forecast, By Country
10.5.1 Germany
10.5.1.1 Market Size and Forecast, By Product Type
10.5.1.2 Market Size and Forecast, By Application
10.5.1.3 Market Size and Forecast, By End User
10.5.2 France
10.5.2.1 Market Size and Forecast, By Product Type
10.5.2.2 Market Size and Forecast, By Application
10.5.2.3 Market Size and Forecast, By End User
10.5.3 UK
10.5.3.1 Market Size and Forecast, By Product Type
10.5.3.2 Market Size and Forecast, By Application
10.5.3.3 Market Size and Forecast, By End User
10.5.4 Russia
10.5.4.1 Market Size and Forecast, By Product Type
10.5.4.2 Market Size and Forecast, By Application
10.5.4.3 Market Size and Forecast, By End User
10.5.5 Italy
10.5.5.1 Market Size and Forecast, By Product Type
10.5.5.2 Market Size and Forecast, By Application
10.5.5.3 Market Size and Forecast, By End User
10.6.6 Spain
10.5.6.1 Market Size and Forecast, By Product Type
10.5.6.2 Market Size and Forecast, By Application
10.5.6.3 Market Size and Forecast, By End User
10.6.7 Rest of Europe
10.5.7.1 Market Size and Forecast, By Product Type
10.5.7.2 Market Size and Forecast, By Application
10.5.7.3 Market Size and Forecast, By End User
11 Asia Pacific Implantable Infusion Pumps Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Implantable Infusion Pumps Market Share Analysis, By Product Type
11.3 Asia Pacific Implantable Infusion Pumps Market Size and Forecast, By Application
11.4 Asia Pacific Implantable Infusion Pumps Market Size and Forecast, By End User
11.5 Asia Pacific Implantable Infusion Pumps Market Size and Forecast, By Country
11.5.1 China
11.5.1.1 Market Size and Forecast, By Product Type
11.5.1.2 Market Size and Forecast, By Application
11.5.1.3 Market Size and Forecast, By End User
11.5.2 Japan
11.5.2.1 Market Size and Forecast, By Product Type
11.5.2.2 Market Size and Forecast, By Application
11.5.2.3 Market Size and Forecast, By End User
11.5.3 India
11.5.3.1 Market Size and Forecast, By Product Type
11.5.3.2 Market Size and Forecast, By Application
11.5.3.3 Market Size and Forecast, By End User
11.5.4 South Korea
11.5.4.1 Market Size and Forecast, By Product Type
11.5.4.2 Market Size and Forecast, By Application
11.5.4.3 Market Size and Forecast, By End User
11.5.5 Australia
11.5.5.1 Market Size and Forecast, By Product Type
11.5.5.2 Market Size and Forecast, By Application
11.5.5.3 Market Size and Forecast, By End User
11.5.6 New Zealand
11.5.6.1 Market Size and Forecast, By Product Type
11.5.6.2 Market Size and Forecast, By Application
11.5.6.3 Market Size and Forecast, By End User
11.5.7 Singapore
11.5.7.1 Market Size and Forecast, By Product Type
11.5.7.2 Market Size and Forecast, By Application
11.5.7.3 Market Size and Forecast, By End User
11.5.8 Malaysia
11.5.8.1 Market Size and Forecast, By Product Type
11.5.8.2 Market Size and Forecast, By Application
11.5.8.3 Market Size and Forecast, By End User
11.5.9 Rest of Asia Pacific
11.5.9.1 Market Size and Forecast, By Product Type
11.5.9.2 Market Size and Forecast, By Application
11.5.9.3 Market Size and Forecast, By End User
12 Latin America Implantable Infusion Pumps Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Implantable Infusion Pumps Market Share Analysis, By Product Type
12.3 Latin America Implantable Infusion Pumps Market Size and Forecast, By Application
12.4 Latin America Implantable Infusion Pumps Market Size and Forecast, By End User
12.5 Latin America Implantable Infusion Pumps Market Size and Forecast, Country
12.5.1 Brazil
12.5.1.1 Market Size and Forecast, By Product Type
12.5.1.2 Market Size and Forecast, By Application
12.5.1.3 Market Size and Forecast, By End User
12.5.2 Argentina
12.5.2.1 Market Size and Forecast, By Product Type
12.5.2.2 Market Size and Forecast, By Application
12.5.1.3 Market Size and Forecast, By End User
12.5.3 Colombia
12.5.3.1 Market Size and Forecast, By Product Type
12.5.3.2 Market Size and Forecast, By Application
12.5.3.3 Market Size and Forecast, By End User
12.5.4 Peru
12.5.4.1 Market Size and Forecast, By Product Type
12.5.4.2 Market Size and Forecast, By Application
12.5.4.3 Market Size and Forecast, By End User
12.5.5 Chile
12.5.5.1 Market Size and Forecast, By Product Type
12.5.5.2 Market Size and Forecast, By Application
12.5.5.3 Market Size and Forecast, By End User
12.5.6 Venezuela
12.5.6.1 Market Size and Forecast, By Product Type
12.5.6.2 Market Size and Forecast, By Application
12.5.6.3 Market Size and Forecast, By End User
12.5.7 Rest of Latin America
12.5.7.1 Market Size and Forecast, By Product Type
12.5.7.2 Market Size and Forecast, By Application
12.5.7.3 Market Size and Forecast, By End User
14 Middle East Implantable Infusion Pumps Market Analysis and Forecast (2023-2030)
14.1 Introduction
14.2 Middle East Implantable Infusion Pumps Market Share Analysis, By Product Type
14.3 Middle East Implantable Infusion Pumps Market Size and Forecast, By Application
14.4 Middle East Implantable Infusion Pumps Market Size and Forecast, By End User
14.5 Middle East Implantable Infusion Pumps Market Size and Forecast, By Country
14.5.1 Saudi Arabia
14.5.1.1 Market Size and Forecast, By Product Type
14.5.1.2 Market Size and Forecast, By Application
14.5.1.3 Market Size and Forecast, By End User
14.5.2 UAE
14.5.2.1 Market Size and Forecast, By Product Type
14.5.2.2 Market Size and Forecast, By Application
14.5.2.3 Market Size and Forecast, By End User
14.5.3 Egypt
14.5.3.1 Market Size and Forecast, By Product Type
14.5.3.2 Market Size and Forecast, By Application
14.5.3.3 Market Size and Forecast, By End User
14.5.4 Kuwait
14.5.4.1 Market Size and Forecast, By Product Type
14.5.4.2 Market Size and Forecast, By Application
14.5.4.3 Market Size and Forecast, By End User
14.5.5 South Africa
14.5.5.1 Market Size and Forecast, By Product Type
14.5.5.2 Market Size and Forecast, By Application
14.5.5.3 Market Size and Forecast, By End User
14.5.6 Rest Middle East & Africa
14.5.6.1 Market Size and Forecast, By Product Type
14.5.6.2 Market Size and Forecast, By Application
14.5.6.3 Market Size and Forecast, By End User
15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1 Hoffmann-La Roche Ltd (Switzerland)
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 B.Braun Melsungen AG (Germany)
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Novo Nordisk A/S (Denmark)
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Medtronic (Ireland)
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Teleflex Incorporated (U.S.)
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Pfizer Inc.(U.S.)
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Baxter (U.S.)
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8 AngioDynamics (U.S.)
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 Smith + Nephew (U.S.)
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
16.10 Johnson and Johnson Services, Inc. (U.S.)
16.10.1 Overview
16.10.2 Offerings
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies
